Genetic testing for hereditary cancer offers invaluable insights into your risk for many adult-onset cancers. Many cancers are associated with specific, inheritable gene mutations that can be detected long before a clinical diagnosis is ever made.
It is important to understand that these gene mutations indicate a risk—they do not determine with 100% certainty that you will develop cancer. However, by identifying these markers early, you and your healthcare provider can make informed, proactive decisions that may significantly lower your overall risk.
Our genetic panels screen for mutations associated with:
Understanding CGx Test Results
Our detailed Carcinogenetic (CGx) test analyzes critical genes and tumor markers to assess your risk for developing or redeveloping cancer:
| BRCA1 | BRCA2 | ATM | CDH1 |
| MLH1 | MSH2 | MSH6 | PTEN |
Clinical Note: If a gene mutation or tumor marker appears in a close relative, your statistical risk of a similar diagnosis can be up to 8 times higher than the general population.
What to Expect from the Process
At One Health Specialty Labs, we specialize in high-complexity molecular testing, but we make the experience simple for the patient.
Emotional Support & Transparency
We recognize that genetic results can have a deep emotional impact on you and your family. In the interest of total transparency and support, One Health Specialty Labs offers expert genetic counseling sessions both before and after your testing to ensure you never have to navigate this data alone.